Rezultati - Steven R. Zeldenrust
- Showing 1 - 20 results of 66
- Go to Next Page
-
1
-
2
-
3
Reduction in C‐reactive protein indicates successful targeting of the IL‐1/IL‐6 axis resulting in improved survival in early stage multiple myeloma od John A. Lust, Martha Q. Lacy, Steven R. Zeldenrust, Thomas E. Witzig, Laurie L. Moon‐Tasson, Charles A. Dinarello, Kathleen A. Donovan
Izdano 2016Artigo -
4
Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients With Previous Diagnosis of Multiple Myeloma od Sumit Madan, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Steven R. Zeldenrust, S. Vincent Rajkumar, Morie A. Gertz, Shaji Kumar
Izdano 2010Artigo -
5
Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics od Julie A. Vrana, Jason D. Theis, Surendra Dasari, Oana Madalina Mereuta, Angela Dispenzieri, Steven R. Zeldenrust, MA Gertz, Paul J. Kurtin, Karen L. Grogg, Ahmet Doǧan
Izdano 2014Artigo -
6
Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry od Taxiarchis Kourelis, Surendra Dasari, Jason D. Theis, Marina Ramı́rez-Alvarado, Paul J. Kurtin, Morie A. Gertz, Steven R. Zeldenrust, Roman M. Zenka, Ahmet Doǧan, Angela Dispenzieri
Izdano 2016Artigo -
7
Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System od Martha Grogan, Christopher G. Scott, Robert A. Kyle, Steven R. Zeldenrust, Morie A. Gertz, Grace Lin, Kyle W. Klarich, Wayne L. Miller, Joseph J. Maleszewski, Angela Dispenzieri
Izdano 2016Artigo -
8
Changes in serum‐free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis od Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Steven R. Zeldenrust, Tow Shung Tan, Shirshendu Sinha, Nelson Leung, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz
Izdano 2010Artigo -
9
Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction od Selma F. Mohammed, Sultan A. Mirzoyev, William D. Edwards, Ahmet Doǧan, Donna R. Grogan, Shannon M. Dunlay, Véronique L. Roger, Morie A. Gertz, Angela Dispenzieri, Steven R. Zeldenrust, Margaret M. Redfield
Izdano 2014Artigo -
10
Mass Spectrometric–Based Proteomic Analysis of Amyloid Neuropathy Type in Nerve Tissue od Christopher J. Klein, Julie A. Vrana, Jason D. Theis, P. James B. Dyck, P. James B. Dyck, Robert J. Spinner, Michelle L. Mauermann, H. Robert Bergen, Steven R. Zeldenrust, Ahmet Doǧan
Izdano 2010Artigo -
11
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma od Sumit Madan, Martha Q. Lacy, Angela Dispenzieri, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, Kristen Detweiler‐Short, David Dingli, Steven R. Zeldenrust, John A. Lust, Philip R. Greipp, S. Vincent Rajkumar, Shaji Kumar
Izdano 2011Artigo -
12
Improved survival in multiple myeloma and the impact of novel therapies od Shaji Kumar, S. Vincent Rajkumar, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Steven R. Zeldenrust, David Dingli, Stephen J. Russell, John A. Lust, Philip R. Greipp, Robert A. Kyle, Morie A. Gertz
Izdano 2007Artigo -
13
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney od Morie A. Gertz, Nelson Leung, M. Q. Lacy, Angela Dispenzieri, Steven R. Zeldenrust, S. R. Hayman, Francis K. Buadi, D. Dingli, Philip R. Greipp, Shaji Kumar, John A. Lust, S. Vincent Rajkumar, Stephen J. Russell, T. E. Witzig
Izdano 2009Artigo -
14
Biologic and genetic characterization of the novel amyloidogenic lambda light chain–secreting human cell lines, ALMC-1 and ALMC-2 od Bonnie K. Arendt, Marina Ramı́rez-Alvarado, Laura A. Sikkink, Jonathan J. Keats, Gregory Ahmann, Angela Dispenzieri, Rafaël Fonseca, Rhett P. Ketterling, Ryan A. Knudson, Erin M. Mulvihill, Renee C. Tschumper, Xiaosheng Wu, Steven R. Zeldenrust, Diane F. Jelinek
Izdano 2008Artigo -
15
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis od Angela Dispenzieri, Martha Q. Lacy, Steven R. Zeldenrust, Suzanne R. Hayman, Shaji Kumar, Susan M. Geyer, John A. Lust, Jacob B. Allred, Thomas E. Witzig, S. Vincent Rajkumar, Philip R. Greipp, Stephen J. Russell, Brian Kabat, Morie A. Gertz
Izdano 2006Artigo -
16
Clinical implication of centrosome amplification in plasma cell neoplasm od Wee Joo Chng, Greg Ahmann, Kim Henderson, Rafael Santana‐Davila, Philip R. Greipp, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, Shaji Kumar, S. Vincent Rajkumar, John A. Lust, Robert A. Kyle, Steven R. Zeldenrust, Suzanne R. Hayman, Rafaël Fonseca
Izdano 2005Artigo -
17
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis od Gregory P. Kaufman, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Nelson Leung, David Dingli, John A. Lust, Yi Lin, Prashant Kapoor, Ronald S. Go, Steven R. Zeldenrust, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar
Izdano 2014Artigo -
18
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients od Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Shivlal Pandey, Prashant Kapoor, David Dingli, Suzanne R. Hayman, Nelson Leung, John A. Lust, Arleigh McCurdy, Stephen J. Russell, Steven R. Zeldenrust, Robert A. Kyle, S. Vincent Rajkumar
Izdano 2013Artigo -
19
Trends in survival of patients with primary plasma cell leukemia: a population-based analysis od Wilson I. Gonsalves, S. Vincent Rajkumar, Ronald S. Go, Angela Dispenzieri, Vinay Gupta, Preet Paul Singh, Francis K. Buadi, Martha Q. Lacy, Prashant Kapoor, David Dingli, John A. Lust, Steven R. Zeldenrust, Suzanne R. Hayman, Robert A. Kyle, Morie A. Gertz, Shaji Kumar
Izdano 2014Artigo -
20
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis od Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, Martha Q. Lacy, Mary F. Burritt, Terry M. Therneau, Philip R. Greipp, Thomas E. Witzig, John A. Lust, S. Vincent Rajkumar, Rafaël Fonseca, Steven R. Zeldenrust, Christopher G.A. McGregor, Allan S. Jaffe
Izdano 2004Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Multiple myeloma
Gastroenterology
Immunology
Antibody
Surgery
Amyloidosis
Immunoglobulin light chain
Oncology
AL amyloidosis
Biology
Pathology
Dexamethasone
Lenalidomide
Autologous stem-cell transplantation
Chemotherapy
Disease
Transplantation
Cohort
Confidence interval
Intensive care medicine
Pomalidomide
Hazard ratio
Heart failure
Paleontology
Plasma cell dyscrasia
Polyneuropathy
Thalidomide
Transthyretin